CV Sciences (CVSI) EPS (Diluted) (QoQ) (2017 - 2026)
CV Sciences (CVSI) EPS (Diluted) (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.85% |
| Mar 31, 2026 | -493.70% |
| Dec 31, 2025 | 142.15% |
| Sep 30, 2025 | -46.36% |
| Jun 30, 2025 | -139.45% |
| Mar 31, 2025 | 77.66% |
| Dec 31, 2024 | -5.85% |
| Sep 30, 2024 | 26.13% |
| Jun 30, 2024 | 12.05% |
| Mar 31, 2024 | 31.77% |
| Dec 31, 2023 | -95.23% |
| Sep 30, 2023 | 65.75% |
| Jun 30, 2023 | -122.50% |
| Mar 31, 2023 | 323.87% |
| Dec 31, 2022 | -138.15% |
| Sep 30, 2022 | 73.33% |
| Jun 30, 2022 | -45.76% |
| Mar 31, 2022 | 77.96% |
| Dec 31, 2021 | -22,309.07% |
| Sep 30, 2021 | 98.88% |